JP2006514681A5 - - Google Patents

Download PDF

Info

Publication number
JP2006514681A5
JP2006514681A5 JP2004572190A JP2004572190A JP2006514681A5 JP 2006514681 A5 JP2006514681 A5 JP 2006514681A5 JP 2004572190 A JP2004572190 A JP 2004572190A JP 2004572190 A JP2004572190 A JP 2004572190A JP 2006514681 A5 JP2006514681 A5 JP 2006514681A5
Authority
JP
Japan
Prior art keywords
epothilone
pharmaceutical composition
concentration
intravenous infusion
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004572190A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006514681A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/017921 external-priority patent/WO2004103267A2/en
Publication of JP2006514681A publication Critical patent/JP2006514681A/ja
Publication of JP2006514681A5 publication Critical patent/JP2006514681A5/ja
Pending legal-status Critical Current

Links

JP2004572190A 2002-05-20 2003-05-20 エポチロンdの投与方法 Pending JP2006514681A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38216602P 2002-05-20 2002-05-20
PCT/US2003/017921 WO2004103267A2 (en) 2002-05-20 2003-05-20 Methods to administer epothilone d

Publications (2)

Publication Number Publication Date
JP2006514681A JP2006514681A (ja) 2006-05-11
JP2006514681A5 true JP2006514681A5 (cg-RX-API-DMAC7.html) 2006-07-13

Family

ID=33476529

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004572190A Pending JP2006514681A (ja) 2002-05-20 2003-05-20 エポチロンdの投与方法

Country Status (7)

Country Link
US (1) US20040072882A1 (cg-RX-API-DMAC7.html)
EP (1) EP1575556A2 (cg-RX-API-DMAC7.html)
JP (1) JP2006514681A (cg-RX-API-DMAC7.html)
KR (1) KR20050043796A (cg-RX-API-DMAC7.html)
CN (1) CN101389334A (cg-RX-API-DMAC7.html)
AU (1) AU2003296878A1 (cg-RX-API-DMAC7.html)
WO (1) WO2004103267A2 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1386922B1 (en) * 1996-12-03 2012-04-11 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereof, analogues and uses thereof
US20020058286A1 (en) * 1999-02-24 2002-05-16 Danishefsky Samuel J. Synthesis of epothilones, intermediates thereto and analogues thereof
US8618085B2 (en) * 2000-04-28 2013-12-31 Koasn Biosciences Incorporated Therapeutic formulations of desoxyepothilones
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
ATE350383T1 (de) * 2002-08-23 2007-01-15 Sloan Kettering Inst Cancer Synthese von epothilonen, zwischenprodukte dafür, analoga und deren verwendungen
US6921769B2 (en) 2002-08-23 2005-07-26 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
CN1870995A (zh) * 2003-09-02 2006-11-29 诺瓦提斯公司 使用埃坡霉素的癌症治疗
US20050171167A1 (en) * 2003-11-04 2005-08-04 Haby Thomas A. Process and formulation containing epothilones and analogs thereof
US20050215604A1 (en) * 2004-03-26 2005-09-29 Kosan Biosciences, Inc. Combination therapies with epothilones and carboplatin
EP2634252B1 (en) 2005-02-11 2018-12-19 University of Southern California Method of expressing proteins with disulfide bridges
US8008256B2 (en) * 2006-05-01 2011-08-30 University Of Southern California Combination therapy for treatment of cancer
KR101604864B1 (ko) * 2008-04-25 2016-03-18 에이에스엠 인터내셔널 엔.브이. 텔루르와 셀렌 박막의 원자층 증착을 위한 전구체의 합성과 그 용도
US8802394B2 (en) 2008-11-13 2014-08-12 Radu O. Minea Method of expressing proteins with disulfide bridges with enhanced yields and activity
WO2011056519A2 (en) 2009-10-26 2011-05-12 Asm International N.V. Synthesis and use of precursors for ald of group va element containing thin films
CA2927832C (en) 2010-05-18 2021-03-23 Cerulean Pharma Inc. Cyclodextrin-containing polymer-therapeutic agent conjugates and their use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL189698B1 (pl) * 1996-03-12 2005-09-30 Pg Txl Co Kompozycja farmaceutyczna zawierająca lek przeciwnowotworowy i jej zastosowania
EP1386922B1 (en) * 1996-12-03 2012-04-11 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereof, analogues and uses thereof
AU738576B2 (en) * 1997-12-04 2001-09-20 Bristol-Myers Squibb Company A process for the reduction of oxiranyl epothilones to olefinic epothilones
US6194181B1 (en) * 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
US6302838B1 (en) * 1998-02-25 2001-10-16 Novartis Ag Cancer treatment with epothilones
CN100381566C (zh) * 1998-11-20 2008-04-16 科森生物科学公司 产生环氧噻酮及其衍生物的重组方法和材料
ES2273688T3 (es) * 1999-04-14 2007-05-16 Dana-Farber Cancer Institute, Inc. Procedimiento y composicion para el tratamiento de cancer.
WO2001064650A2 (en) * 2000-03-01 2001-09-07 Sloan-Kettering Institute For Cancer Research Center Synthesis of epothilones, intermediates thereto and analogues thereof
WO2001083800A2 (en) * 2000-04-28 2001-11-08 Kosan Biosciences, Inc. Heterologous production of polyketides
AU7902501A (en) * 2000-07-25 2002-02-05 Kosan Biosciences Inc Fermentation process for epothilones

Similar Documents

Publication Publication Date Title
JP2007515469A5 (cg-RX-API-DMAC7.html)
JP2005520778A5 (cg-RX-API-DMAC7.html)
JP2006523216A5 (cg-RX-API-DMAC7.html)
CA2393437A1 (en) Exo-s-mecamylamine formulation and use in treatment
JP2012067116A5 (cg-RX-API-DMAC7.html)
JP2012521435A5 (cg-RX-API-DMAC7.html)
JP2007514749A5 (cg-RX-API-DMAC7.html)
JP2009545600A5 (cg-RX-API-DMAC7.html)
JP2006513184A5 (cg-RX-API-DMAC7.html)
JP2002544231A5 (cg-RX-API-DMAC7.html)
JP2013541583A5 (cg-RX-API-DMAC7.html)
JP2008514577A5 (cg-RX-API-DMAC7.html)
TWI441639B (zh) 用於治療卵巢癌之包含紫杉醇之組合
JP2009517411A5 (cg-RX-API-DMAC7.html)
JP2003514025A5 (cg-RX-API-DMAC7.html)
JP2002530353A5 (cg-RX-API-DMAC7.html)
JP2011500589A5 (cg-RX-API-DMAC7.html)
JP2002544227A5 (cg-RX-API-DMAC7.html)
IL194500A (en) A peptide substance capable of increasing capillary resistance and pharmacological preparation containing the above
CN101856498B (zh) 一种抗感染性休克的药物组合物及其应用
JP2008517991A5 (cg-RX-API-DMAC7.html)
CA2563058A1 (en) Supportive treatment of liver disease
JP2003511396A5 (cg-RX-API-DMAC7.html)
JP2010106019A (ja) リマプロストを含有してなる癌化学療法に起因する末梢神経障害予防、治療および/または症状軽減剤
WO2007056263A3 (en) Methods of treating cancer with high potency lipid-based platinum compound formulations administered intravenously